Autolus Therapeutics PLC (AUTL)

2.29 +0.05 (+2.23%) USD  |  NASDAQ  |  Dec 20, 16:00
2.285 0.00 (0.00%) After-Hours: 20:00
More

Autolus Therapeutics Enterprise Value: -47.65M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
TC BioPharm (Holdings) PLC 4.212M
Adaptimmune Therapeutics PLC 18.53M
Biodexa Pharmaceuticals PLC -3.645M
Bicycle Therapeutics PLC 122.73M
DBV Technologies SA 19.71M

Enterprise Value Related Metrics

Net Income (Quarterly) -82.09M
Total Expenses (Quarterly) 67.65M
EPS Diluted (Quarterly) -0.31
Earnings Yield -53.28%
Normalized Earnings Yield -52.41